Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Is a | Product containing glycopyrronium bromide (medicinal product) | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Has active ingredient | Glycopyrronium bromide | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glycopyrronium bromide 200micrograms/1mL injection | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrronium bromide 600micrograms/3mL injection | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 1mL vial (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 5mL vial (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 20mL vial (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrrolate 0.2mg/mL injection solution 2mL vial (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Neostigmine+glycopyrronium (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule (product) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule (clinical drug) | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrronium bromide 600 microgram/3 mL solution for injection ampoule | Is a | False | Product containing glycopyrronium bromide in parenteral dosage form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set